| Company/Division name | Lonza Biologics Inc |
| Parent company | Lonza Group |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 1000 |
| Year reshoring announced: | 2018 |
| Country(ies) from which reshored: | Switzerland |
| City reshored to: | Portsmouth |
| State(s) reshored to: | NH |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | harmaceutical, biotech and specialty ingredients |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Infrastructure, Impact on domestic economy, Under-utilized capacity |
